Overview

Impact Of RA Therapy Compliance On Patient-Reported Outcomes

Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
Several observational studies have evaluated the comparative treatment costs associated with each agent, particularly those within the anti-TNF class, but few have evaluated the impact of therapy compliance, persistence, treatment patterns on patient reported outcomes, healthcare utilization and costs, using a provider database. This study is designed to fill in this information gap.
Details
Lead Sponsor:
Pfizer